IL1B and amyotrophic lateral sclerosis: Importantly, it has been shown that 24S-HC will also inhibit SREBP-driven cholesterol biosynthesis (52), so, conversely, reduced levels of 24S-HC in the CNS, as observed in ALS, should result in enhanced cholesterol biosynthesis and Il1b transcription, inflammasome activity, and neuroinflammation.